AQP4 and neuromyelitis optica: AQP4-IgG titers in sera of NMO patients significantly decrease after treatment with high-dose intravenous methylprednisolone and remain low under an immunosuppressive therapy with oral prednisolone and azathioprine [29,30], as well as cyclophosphamide and rituximab [30].